Equity Overview
Price & Market Data
Price: $26.20
Daily Change: +$1.14 / 4.35%
Daily Range: $25.20 - $26.25
Market Cap: $683,749,376
Daily Volume: 5,807
Performance Metrics
1 Week: 10.98%
1 Month: 49.17%
3 Months: 49.79%
6 Months: 25.74%
1 Year: 111.5%
YTD: 48.20%
Company Details
Employees: 44
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Eton Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing treatments for rare diseases. Its commercial rare disease products include Increlex for the treatment of severe primary igf-1 deficiency; Alkindi Sprinkle for adrenal insufficiency; Khindivi for adrenocortical insufficiency; Galzin for Wilson disease; PKU Golike for phenylketonuria; Carglumic Acid for N-acetylglutamate synthase deficiency; Betaine Anhydrous for homocystinuria; and Nitisinone for tyrosinemia type 1. The company is also developing various product candidates, which are in late-stage development, including ET-600 for diabetes insipidus; Amglidia for neonatal diabetes mellitus; ET-700 for Wilson disease; ET-800 for adrenal insufficiency; and ZENEO hydrocortisone autoinjector for adrenal crisis. Eton Pharmaceuticals, Inc. was incorporated in 2017 and is based in Deer Park, Illinois.